ZimVie Inc.
General ticker "ZIMV" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $374.1M (TTM average)
ZimVie Inc. follows the US Stock Market performance with the rate: 45.3%.
Estimated limits based on current volatility of 0.0%: low 18.99$, high 19.00$
Factors to consider:
- Earnings expected soon, date: 2025-10-29 bmo
- Total employees count: 1770 as of 2024
- US accounted for 59.3% of revenue in the fiscal year ended 2024-12-31
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [10.38$, 18.51$]
- 2025-12-31 to 2026-12-31 estimated range: [9.35$, 17.16$]
Financial Metrics affecting the ZIMV estimates:
- Positive: with PPE of 23.0 at the end of fiscal year the price was very low
- Negative: negative Operating income
- Negative: Industry operating cash flow per share per price (median), % of -3.15 <= 2.35
- Positive: Industry inventory ratio change (median), % of -0.79 <= -0.21
- Positive: 41.86 < Shareholder equity ratio, % of 50.65 <= 62.86
- Negative: Industry earnings per price (median), % of -4.08 <= 0
- Negative: negative Net income
- Positive: 0.85 < Operating cash flow per share per price, % of 3.75
Short-term ZIMV quotes
Long-term ZIMV plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $463.29MM | $457.43MM | $449.75MM |
| Operating Expenses | $509.78MM | $488.37MM | $470.41MM |
| Operating Income | $-46.49MM | $-30.94MM | $-20.66MM |
| Non-Operating Income | $-8.01MM | $-19.91MM | $-2.93MM |
| Interest Expense | $11.08MM | $22.75MM | $18.89MM |
| R&D Expense | $31.15MM | $26.16MM | $26.91MM |
| Income(Loss) | $-54.50MM | $-50.85MM | $-23.59MM |
| Taxes | $-7.60MM | $5.20MM | $10.24MM |
| Other Income(Loss) | $-16.98MM | $-337.23MM | $8.01MM |
| Profit(Loss)* | $-63.88MM | $-730.51MM | $-17.82MM |
| Stockholders Equity | $758.60MM | $409.49MM | $381.71MM |
| Inventory | $233.85MM | $79.60MM | $75.02MM |
| Assets | $1,642.06MM | $1,205.35MM | $753.67MM |
| Operating Cash Flow | $24.63MM | $37.15MM | $14.17MM |
| Capital expenditure | $26.55MM | $12.49MM | $6.68MM |
| Investing Cash Flow | $-28.66MM | $-15.17MM | $282.30MM |
| Financing Cash Flow | $-1.31MM | $-25.67MM | $-294.67MM |
| Earnings Per Share** | $-2.45 | $-27.61 | $-0.65 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.